black box warning glp 1 GLP-1 Agonist Glp1 and thyroid anomalies? :

At this time, retatrutide, one of the best-known triple hormone receptor agonists, is still investigational and has not been approved by any regulatory agency for routine patient use

Weight loss of up to 11.2 kgs

While pain perception varies individually, the typical sensation is a brief pinch lasting only seconds

The best GLP-1 wont be the same option for every patient

The appetite-suppressing effects become stronger, leading to a significant reduction in hunger and food cravings

However, we welcome the governments new direction to prescribers that there is now sufficient stock of Rybelsus to allow new initiation of this medication and hope that many people with T2DM who could benefit will now be able to be initiated onto a GLP-1 for the first time